KEVZARA
KEVZARA
Discontinued
DIN Number
02460521
Drug Class
Human
Market Date
Mar 29, 2017
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02460521
AIG Number0158770001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC14 SARILUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
SARILUMABActive
Strength: 150 MG / 1.14 ML
Monograph: SARILUMAB